As of December 2024, NeuroBo Pharmaceuticals has a market cap of $10.72M. This makes NeuroBo Pharmaceuticals the world's 5222th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $23.31M | 29.94% |
2023 | $17.94M | -35.64% |
2022 | $27.87M | -98.04% |
2021 | $1.42B | -76.76% |
2020 | $6.11B | -40.00% |
2019 | $10.19B | -56.79% |
2018 | $23.58B | -89.80% |
2017 | $231.27B | 1.34% |
2016 | $228.22B | - |